External Quality Assessment for FGFR3 testing in Urothelial

This poster presents the findings of a global pilot External Quality Assessment (EQA) scheme for FGFR3 testing in urothelial (bladder) cancer. With bladder cancer ranking as the ninth most common cancer worldwide, accurate detection of FGFR3 variants and fusions is critical for guiding targeted therapy. The study involved 30 accredited laboratories across 15 countries, assessing […]